• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索利益相关者需求以推动基于医院的通用基础设施中人工智能算法的研发:一项多步骤混合方法研究的结果

Exploring Stakeholder Requirements to Enable Research and Development of Artificial Intelligence Algorithms in a Hospital-Based Generic Infrastructure: Results of a Multistep Mixed Methods Study.

作者信息

Weinert Lina, Klass Maximilian, Schneider Gerd, Heinze Oliver

机构信息

Institute of Medical Informatics, Heidelberg University Hospital, Heidelberg, Germany.

Section for Translational Health Economics, Department for Conservative Dentistry, Heidelberg University Hospital, Heidelberg, Germany.

出版信息

JMIR Form Res. 2023 Apr 18;7:e43958. doi: 10.2196/43958.

DOI:10.2196/43958
PMID:37071450
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10155093/
Abstract

BACKGROUND

Legal, controlled, and regulated access to high-quality data from academic hospitals currently poses a barrier to the development and testing of new artificial intelligence (AI) algorithms. To overcome this barrier, the German Federal Ministry of Health supports the "pAItient" (Protected Artificial Intelligence Innovation Environment for Patient Oriented Digital Health Solutions for developing, testing and evidence-based evaluation of clinical value) project, with the goal to establish an AI Innovation Environment at the Heidelberg University Hospital, Germany. It is designed as a proof-of-concept extension to the preexisting Medical Data Integration Center.

OBJECTIVE

The first part of the pAItient project aims to explore stakeholders' requirements for developing AI in partnership with an academic hospital and granting AI experts access to anonymized personal health data.

METHODS

We designed a multistep mixed methods approach. First, researchers and employees from stakeholder organizations were invited to participate in semistructured interviews. In the following step, questionnaires were developed based on the participants' answers and distributed among the stakeholders' organizations. In addition, patients and physicians were interviewed.

RESULTS

The identified requirements covered a wide range and were conflicting sometimes. Relevant patient requirements included adequate provision of necessary information for data use, clear medical objective of the research and development activities, trustworthiness of the organization collecting the patient data, and data should not be reidentifiable. Requirements of AI researchers and developers encompassed contact with clinical users, an acceptable user interface (UI) for shared data platforms, stable connection to the planned infrastructure, relevant use cases, and assistance in dealing with data privacy regulations. In a next step, a requirements model was developed, which depicts the identified requirements in different layers. This developed model will be used to communicate stakeholder requirements within the pAItient project consortium.

CONCLUSIONS

The study led to the identification of necessary requirements for the development, testing, and validation of AI applications within a hospital-based generic infrastructure. A requirements model was developed, which will inform the next steps in the development of an AI innovation environment at our institution. Results from our study replicate previous findings from other contexts and will add to the emerging discussion on the use of routine medical data for the development of AI applications.

INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.2196/42208.

摘要

背景

目前,从学术医院获取合法、受控且规范的高质量数据,对新型人工智能(AI)算法的开发与测试构成了障碍。为克服这一障碍,德国联邦卫生部支持“pAItient”(面向患者的数字健康解决方案的受保护人工智能创新环境,用于临床价值的开发、测试和循证评估)项目,目标是在德国海德堡大学医院建立一个人工智能创新环境。它被设计为对现有医学数据整合中心的概念验证扩展。

目的

“pAItient”项目的第一部分旨在探索利益相关者在与学术医院合作开发人工智能以及允许人工智能专家访问匿名个人健康数据方面的需求。

方法

我们设计了一种多步骤混合方法。首先,邀请利益相关者组织的研究人员和员工参加半结构化访谈。接下来,根据参与者的回答制定问卷,并在利益相关者组织中分发。此外,还对患者和医生进行了访谈。

结果

确定的需求范围广泛,有时相互冲突。相关的患者需求包括为数据使用充分提供必要信息、研发活动明确的医学目标、收集患者数据的组织的可信度以及数据不应可重新识别。人工智能研究人员和开发人员的需求包括与临床用户的联系、共享数据平台可接受的用户界面(UI)、与计划基础设施的稳定连接、相关用例以及处理数据隐私法规方面的协助。下一步,开发了一个需求模型,该模型在不同层次描述了确定的需求。这个开发的模型将用于在“pAItient”项目联盟内传达利益相关者的需求。

结论

该研究确定了在基于医院的通用基础设施内开发、测试和验证人工智能应用的必要需求。开发了一个需求模型,这将为我们机构人工智能创新环境的下一步发展提供信息。我们研究的结果重复了其他背景下的先前发现,并将为关于使用常规医疗数据开发人工智能应用的新兴讨论增添内容。

国际注册报告识别号(IRRID):RR2 - 10.2196/42208。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9105/10155093/bde3c65511a4/formative_v7i1e43958_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9105/10155093/bde3c65511a4/formative_v7i1e43958_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9105/10155093/bde3c65511a4/formative_v7i1e43958_fig1.jpg

相似文献

1
Exploring Stakeholder Requirements to Enable Research and Development of Artificial Intelligence Algorithms in a Hospital-Based Generic Infrastructure: Results of a Multistep Mixed Methods Study.探索利益相关者需求以推动基于医院的通用基础设施中人工智能算法的研发:一项多步骤混合方法研究的结果
JMIR Form Res. 2023 Apr 18;7:e43958. doi: 10.2196/43958.
2
Exploring Stakeholder Requirements to Enable the Research and Development of Artificial Intelligence Algorithms in a Hospital-Based Generic Infrastructure: Protocol for a Multistep Mixed Methods Study.探索利益相关者需求以推动基于医院的通用基础设施中人工智能算法的研发:一项多步骤混合方法研究方案
JMIR Res Protoc. 2022 Dec 16;11(12):e42208. doi: 10.2196/42208.
3
Exploring Physician Perspectives on Using Real-world Care Data for the Development of Artificial Intelligence-Based Technologies in Health Care: Qualitative Study.探索医生对利用真实世界医疗数据开发医疗保健领域人工智能技术的看法:定性研究
JMIR Form Res. 2022 May 18;6(5):e35367. doi: 10.2196/35367.
4
Future Medical Artificial Intelligence Application Requirements and Expectations of Physicians in German University Hospitals: Web-Based Survey.德国大学医院的未来医学人工智能应用要求和医生期望:基于网络的调查。
J Med Internet Res. 2021 Mar 5;23(3):e26646. doi: 10.2196/26646.
5
Clinicians' roles and necessary levels of understanding in the use of artificial intelligence: A qualitative interview study with German medical students.临床医生在使用人工智能方面的角色和必要的理解水平:一项对德国医学生的定性访谈研究。
BMC Med Ethics. 2024 Oct 7;25(1):107. doi: 10.1186/s12910-024-01109-w.
6
Physicians' and Machine Learning Researchers' Perspectives on Ethical Issues in the Early Development of Clinical Machine Learning Tools: Qualitative Interview Study.医生和机器学习研究人员对临床机器学习工具早期开发中伦理问题的看法:定性访谈研究
JMIR AI. 2023 Oct 30;2:e47449. doi: 10.2196/47449.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
Learning From International Comparators of National Medical Imaging Initiatives for AI Development: Multiphase Qualitative Study.从国家医学影像人工智能发展倡议的国际比较中学习:多阶段定性研究
JMIR AI. 2024 Jan 4;3:e51168. doi: 10.2196/51168.
10
Ambient Assisted Living: Scoping Review of Artificial Intelligence Models, Domains, Technology, and Concerns.环境辅助生活:人工智能模型、领域、技术和关注点的范围综述。
J Med Internet Res. 2022 Nov 4;24(11):e36553. doi: 10.2196/36553.

引用本文的文献

1
Policy Challenges in Ultra-Rare Cancers: Ethical, Social, and Legal Implications of Melanoma Prevention and Diagnosis in Children, Adolescents, and Young Adults.超罕见癌症的政策挑战:儿童、青少年和青年黑色素瘤预防与诊断的伦理、社会和法律影响
Healthcare (Basel). 2025 Feb 4;13(3):321. doi: 10.3390/healthcare13030321.
2
Insights on the Current State and Future Outlook of AI in Health Care: Expert Interview Study.医疗保健领域人工智能的现状与未来展望洞察:专家访谈研究
JMIR AI. 2023 Oct 31;2:e47353. doi: 10.2196/47353.

本文引用的文献

1
Exploring Stakeholder Requirements to Enable the Research and Development of Artificial Intelligence Algorithms in a Hospital-Based Generic Infrastructure: Protocol for a Multistep Mixed Methods Study.探索利益相关者需求以推动基于医院的通用基础设施中人工智能算法的研发:一项多步骤混合方法研究方案
JMIR Res Protoc. 2022 Dec 16;11(12):e42208. doi: 10.2196/42208.
2
Attitudes and perception of artificial intelligence in healthcare: A cross-sectional survey among patients.患者对医疗保健中人工智能的态度和认知:一项横断面调查
Digit Health. 2022 Aug 8;8:20552076221116772. doi: 10.1177/20552076221116772. eCollection 2022 Jan-Dec.
3
Perspective of Information Technology Decision Makers on Factors Influencing Adoption and Implementation of Artificial Intelligence Technologies in 40 German Hospitals: Descriptive Analysis.
德国40家医院信息技术决策者对影响人工智能技术采用与实施因素的看法:描述性分析
JMIR Med Inform. 2022 Jun 15;10(6):e34678. doi: 10.2196/34678.
4
Aligning mission to digital health strategy in academic medical centers.在学术医疗中心将使命与数字健康战略相结合。
NPJ Digit Med. 2022 Jun 2;5(1):67. doi: 10.1038/s41746-022-00608-7.
5
Exploring Physician Perspectives on Using Real-world Care Data for the Development of Artificial Intelligence-Based Technologies in Health Care: Qualitative Study.探索医生对利用真实世界医疗数据开发医疗保健领域人工智能技术的看法:定性研究
JMIR Form Res. 2022 May 18;6(5):e35367. doi: 10.2196/35367.
6
CHAIMELEON Project: Creation of a Pan-European Repository of Health Imaging Data for the Development of AI-Powered Cancer Management Tools.变色龙项目:创建一个泛欧健康影像数据存储库,用于开发人工智能驱动的癌症管理工具。
Front Oncol. 2022 Feb 24;12:742701. doi: 10.3389/fonc.2022.742701. eCollection 2022.
7
Population Preferences for Performance and Explainability of Artificial Intelligence in Health Care: Choice-Based Conjoint Survey.人群对医疗人工智能性能和可解释性的偏好:基于选择的联合调查。
J Med Internet Res. 2021 Dec 13;23(12):e26611. doi: 10.2196/26611.
8
Data Sharing in Distributed Architectures - Concept and Implementation in HiGHmed.分布式架构中的数据共享 - HiGHmed 中的概念与实现。
Stud Health Technol Inform. 2021 Sep 21;283:111-118. doi: 10.3233/SHTI210548.
9
Role of Artificial Intelligence Applications in Real-Life Clinical Practice: Systematic Review.人工智能应用在实际临床实践中的作用:系统评价
J Med Internet Res. 2021 Apr 22;23(4):e25759. doi: 10.2196/25759.
10
The use of personal health information outside the circle of care: consent preferences of patients from an academic health care institution.医疗照护范围之外的个人健康信息使用:来自一所学术性医疗机构患者的同意偏好
BMC Med Ethics. 2021 Mar 24;22(1):29. doi: 10.1186/s12910-021-00598-3.